Step-by-step optimization of a heterologous pathway for de novo naringenin production in Escherichia coli
Applied Microbiology and Biotechnology · 2024
DOI: 10.1007/s00253-024-13271-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Daniela Gomes und 2 weiteren Autor:innen. Beteiligte Einrichtung: CEB-Centre of Biological Engineering, Universidade Do Minho, Campus de Gualtar, 4710-057, Braga, Portugal. Hauptthemen laut MEDLINE: Flavanones, Escherichia coli, Biosynthetic Pathways, Acyltransferases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Universidade do Minho.
Abstract (Originalsprache)
Naringenin is a plant polyphenol, widely explored due to its interesting biological activities, namely anticancer, antioxidant, and anti-inflammatory. Due to its potential applications and attempt to overcome the industrial demand, there has been an increased interest in its heterologous production. The microbial biosynthetic pathway to produce naringenin is composed of tyrosine ammonia-lyase (TAL), 4-coumarate-CoA ligase (4CL), chalcone synthase (CHS), and chalcone isomerase (CHI). Herein, we targeted the efficient de novo production of naringenin in Escherichia coli by performing a step-by-step validation and optimization of the pathway. For that purpose, we first started by expressing two TAL genes from different sources in three different E. coli strains. The highest p -coumaric acid production (2.54 g/L) was obtained in the tyrosine-overproducing M-PAR-121 strain carrying TAL from Flavobacterium johnsoniae ( FjT AL). Afterwards, this platform strain was used to express different combinations of 4CL and CHS genes from different sources. The highest naringenin chalcone production (560.2 mg/L) was achieved by expressing Fj TAL combined with 4CL from Arabidopsis thaliana ( At 4CL) and CHS from Cucurbita maxima ( Cm CHS). Finally, different CHIs were tested and validated, and 765.9 mg/L of naringenin was produced by expressing CHI from Medicago sativa ( Ms CHI) combined with the other previously chosen genes. To our knowledge, this titer corresponds to the highest de novo production of naringenin reported so far in E. coli . Key points • Best enzyme and strain combination were selected for de novo naringenin production. • After genetic and operational optimizations, 765.9 mg/L of naringenin was produced. • This de novo production is the highest reported so far in E. coli.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CEB-Centre of Biological Engineering, Universidade Do Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
- CEB-Centre of Biological Engineering, Universidade Do Minho, Campus de Gualtar, 4710-057, Braga, Portugal. joanarodrigues@deb.uminho.pt.
- LABBELS - Associate Laboratory, Braga, Guimarães, Portugal. joanarodrigues@deb.uminho.pt.
- LABBELS - Associate Laboratory, Braga, Guimarães, Portugal.
Förderung
- Fundação para a Ciência e a Tecnologia
- Universidade do Minho
Zitieren
APA
Gomes, D., Rodrigues, J. L., & Rodrigues, L. R. (2024). Step-by-step optimization of a heterologous pathway for de novo naringenin production in Escherichia coli. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13271-7
Vancouver
Gomes D, Rodrigues JL, Rodrigues LR. Step-by-step optimization of a heterologous pathway for de novo naringenin production in Escherichia coli. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13271-7
BibTeX
@article{Gomes2024,
author = {Gomes, Daniela and Rodrigues, Joana L and Rodrigues, Ligia R},
title = {Step-by-step optimization of a heterologous pathway for de novo naringenin production in Escherichia coli},
journal = {Applied Microbiology and Biotechnology},
year = {2024},
doi = {10.1007/s00253-024-13271-7}
}
EUVIMED